SR One is a global biotech and healthcare venture capital firm. The company focuses on investing in early-stage life sciences companies that are pursuing innovative science to significantly impact medical practice.

SR One Capital Management

SR One

SR One Capital Management is a transatlantic biotech venture capital firm that seeks to partner with who we believe to be top entrepreneurs, scientists and investment partners in an effort to build elite biotechnology companies. SR One’s mission is to translate innovative technologies into potential next-generation medicines that benefit patients with significant unmet medical needs. SR One has offices in San Francisco, CA and London, UK. For more information, please visit www.srone.com.

CRISPR Therapeutics

Effector Therapeutics

Bicycle Therapeutics

Arcellx

Spero Therapeutics

Turning Point Therapeutics

Genocea Biosciences

MiroBio

Morphic Therapeutic

Nimbus Therapeutics

Nkarta Therapeutics

Progyny

Propeller Health

Translate Bio

COM:SRONE

SR One

locale

market

industry

website

crunchbase

linkedin

founding date

invested in

competitor of

Metrics